Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R and D Committee
Read Article
News
2024
2023
Archive
Search news articles
October 3, 2019
Arvinas Strengthens Scientific Advisory Board With Leaders in Oncology and Neurological Disorders
October 3, 2019
Vor Biopharma Hires Senior Cell and Gene Therapy Leaders as Chief Technology Officer and Vice President of Research
October 3, 2019
Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio
October 1, 2019
Cabaletta Bio Receives IND Clearance from FDA to Initiate First Clinical Trial of DSG3-CAART in Patients with Mucosal Pemphigus Vulgaris
September 25, 2019
Escient Pharmaceuticals Announces Appointment of K. Peter Hirth to Board of Directors
September 13, 2019
Akouos Launches The Sing Registry to Inform Future Therapeutic Development for Genetic Sensorineural Hearing Loss
September 13, 2019
Akouos Discloses Lead Program, AK-OTOF, a Potential Gene Therapy for Sensorineural Hearing Loss
September 13, 2019
Rallybio Broadens Team Capabilities with Addition of Douglas Sheridan, PhD
September 6, 2019
Impel NeuroPharma to Present Data from INP104 Clincial Program at The 19th Congress Of The International Headache Society
September 4, 2019
Impel NeuroPharma Announces Last Patient Enrolled in Phase 3 Trial Evaluating INP104 for the Treatment of Acute Migraine
« Previous Page
1
…
48
49
50
51
52
…
103